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Abstract During the 2009–2010 A/H1N1 influenza pan-
demic, pregnant women infected with the virus experi-
enced excess morbidity and mortality when compared with
other groups. Once a vaccine was available, pregnant
women were a priority group for vaccination. Only a few
studies have reported on the uptake of 2009 A/H1N1
influenza vaccine among pregnant women during the
pandemic and none were from Asia. The purpose of this
study was to examine factors associated with 2009 A/H1N1
influenza vaccine uptake among pregnant women in Hong
Kong. Using a multi-center, cross-sectional design, we
recruited 549 postpartum women from four post-natal
wards in Hong Kong over a 4-month period during the
second wave of the A/H1N1 influenza pandemic in the
winter and spring of 2010. Only 6.2% (n = 34) of partic-
ipants had received the 2009 A/H1N1 influenza vaccine
and 4.9% (n = 27) had received the seasonal influenza
vaccine. The most common reasons for not receiving the
2009 A/H1N1 vaccine were fear of causing harm to
themselves or their fetus. A high knowledge level
(OR = 19.06; 95% CI 5.55, 65.48), more positive attitudes
(OR = 3.52; 95% CI 1.37, 9.07), and having a family
member who had the 2009 A/H1N1 influenza vaccine
(OR = 7.69; 95% CI 2.92, 20.19) were independently and
positively associated with vaccination. Study results show
an unacceptably low uptake of the pandemic A/H1N1
influenza vaccine among pregnant women in Hong Kong.
Interventions to increase influenza vaccine knowledge and
uptake among this group should be a priority for future
pandemic planning and seasonal vaccination campaigns.
Keywords H1N1  Pregnancy  Influenza 
Vaccination  Hong Kong
Background
Pregnant women who contract influenza are at a greater
risk of being hospitalized [1, 2], of being hospitalized for
longer duration [3] and of pregnancy complications such as
pre-term labor, fetal distress, and cesarean section [3, 4]. In
addition, the risk of hospitalization for cardiopulmonary
conditions increases progressively as the pregnancy
advances [2, 3, 5]. When compared with their non-pregnant
peers, the risk of hospital admission among pregnant
women is approximately 50% higher from weeks 14–20
and almost fivefold higher in weeks 37–42, resulting in
approximately 2.5 hospitalizations per 1,000 third trimester
women attributable to influenza infection [5]. This level of
risk is equal to or higher than that of persons aged
65–69 years [6] or those with high-risk chronic diseases,
such as cardiac and renal disease, diabetes mellitus, and
immune suppression [5].
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In early 2009, a novel strain of influenza A/H1N1
emerged in Mexico and spread rapidly to almost all other
countries around the globe [7]. In Hong Kong, the first
case of pandemic A/H1N1 influenza was identified on
May 1, 2009 and the disease spread among the population
despite early containment measures [8]. Although the
majority of 2009 A/H1N1 influenza infections produced
only mild symptoms [9], excess morbidity and mortality
were observed in pregnant women during the pandemic
[10, 11]. In the United States (US), a greater proportion of
pregnant women infected with 2009 A/H1N1 influenza
required hospitalization when compared with the general
population (32.4.% vs. 4.2%) and 5–13% of all A/H1N1
influenza deaths in the early part of the pandemic were
among pregnant women [10, 12]. In France, almost 50%
of pregnant women infected with 2009 A/H1N1 influenza
required hospitalization and 13% required admission to an
intensive care unit (ICU) [13]. Overall, pregnant women
were five times more likely than other infected persons to
be admitted to ICU [14]. In the United Kingdom, Aus-
tralia and New Zealand, 10% of pregnant women infected
with 2009 A/H1N1 influenza admitted to an ICU died,
over 10% experienced a pregnancy loss, and over 50%
had a pre-term delivery [15]. In another study of 64
pregnant women with 2009 A/H1N1 influenza in Australia
and New Zealand who were admitted to an ICU, none had
been vaccinated [16]. In Asia, the outcomes for pregnant
women infected with 2009 A/H1N1 influenza were more
favorable [17, 18]. In Hong Kong, 87 pregnant women
with 2009 A/H1N1 infection were admitted to public
hospitals from the beginning of the pandemic up until
May 2010, only one required mechanical ventilation and
none died [19].
While some researchers have questioned both the
necessity and safety of influenza vaccine during pregnancy
[20, 21], Hong Kong [22] and many other countries
[23–25], recommend seasonal influenza vaccines for all
pregnant women during influenza season, regardless of
their gestational age, to reduce the cardiopulmonary com-
plications and hospitalizations associated with influenza
infection [22, 26]. During the A/H1N1 influenza pandemic,
groups that were experiencing the greatest morbidity and
mortality from influenza, such as pregnant women, were
again a priority group for vaccination [25]. In Hong Kong,
the vaccine became available in December 2009 and
pregnant women were prioritized to receive the first
available doses [27]. A previous study on uptake of pre-
pandemic seasonal influenza vaccine among pregnant
women in Hong Kong showed that only 3.9% had been
vaccinated during pregnancy [28]. The purpose of this
study was to examine factors associated with 2009 A/H1N1
influenza vaccine uptake among pregnant women in Hong
Kong.
Methods
Design and Participants
This study used a multi-center, cross-sectional design. New
mothers admitted to the post-natal obstetric units of four
geographically and socio-economically distributed public
hospitals in Hong Kong (two hospitals from Hong Kong
Island and two from the Kowloon Peninsula) were recrui-
ted into the study in the immediate post-partum period.
Each hospital has more than 300 deliveries per month.
Participants were recruited during the second wave of the
A/H1N1 influenza pandemic, from February to June 2010.
The following criteria were used for selection of the study
participants: (1) 18 years of age or older, (2) Cantonese
speaking, (3) singleton pregnancies, (4) Hong Kong resi-
dents, and (5) no serious medical or obstetrical complica-
tions (i.e., infant born at \37 weeks gestation, a birth
weight \2,500 g, admission to the neonatal intensive care
unit, congenital anomalies, or birth defects). All eligible
patients who were on the postnatal ward at the time of data
collection were asked if they would like to participate.
Study Instruments
Participants were recruited during their immediate post-
partum stay and were asked to complete a questionnaire
that consisted of four sections. The first section consisted of
questions about their 2009 A/H1N1 influenza vaccination
status, the vaccination status of family members, provider
recommendations regarding vaccination, reasons for not
being vaccinated and respiratory infections in the partici-
pant or family members. The second section asked ques-
tions about the participants’ health status before and during
the pregnancy. The third section consisted of a 23-item
scale that measured participants’ knowledge (16 items) and
attitudes (7 items) toward pandemic A/H1N1 influenza, the
A/H1H1 influenza vaccine, and A/H1N1 influenza infec-
tion during pregnancy. Participants’ responses were mea-
sured on a 4-point Likert scale (strongly disagree, disagree
somewhat, agree somewhat, strongly agree). Instead of a
5-point scale, a 4-point scale was chosen to mitigate the
risk of obtaining a large proportion of neutral responses,
which has been observed in other studies in this population
[29]. The final section consisted of baseline demographic
data including age, education, income, and employment
status. The questionnaire was adapted from a previously
used survey instrument designed by Tong et al. [30] and
was used with the permission of the researchers. Before
use, the study instrument was translated into Chinese
(Cantonese) by an expert translator. To ensure accuracy of
the translation, back translation of the Chinese version of
the instrument into English was also performed by a
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different translator as per established guidelines [31, 32].
The Chinese version of the questionnaire was reviewed by
two Chinese speaking researchers to ensure that the con-
cepts would be clearly understood by Hong Kong mothers
and that the wording was culturally appropriate.
Data Analysis
The outcome variable was 2009 A/H1N1 influenza vacci-
nation status. Knowledge and attitude items were recoded
into two categories to reflect either correct or incorrect
responses in the case of knowledge items or either positive
or negative responses in the case of attitude items. For both
scales, a total score was calculated by summing all scale
items. Negatively worded items were reverse coded so that
higher scores reflected better knowledge levels and more
positive attitudes. To facilitate further analysis of the effect
of knowledge and attitudes on the study outcome, we
collapsed total scores into categories based on the response
distribution. Knowledge scores were categorized as low
(score 0–5), medium (score 6–10) or high (score 11–16)
and attitude scores were categorized as negative (score
0–2) or positive (score 3–7). Chi-square statistics and
Student’s t tests were performed for the bivariate analyses.
A multiple logistic regression analysis was performed to
estimate the independent contribution, with corresponding
odds ratios (ORs), of study variables to vaccination status.
All variables with a significance level of P \ .05 in the
bivariate analysis were entered into the model and odds
ratios with 95% confidence intervals were calculated. The
Hosmer–Lemeshow test [33] was used to assess the fit of
the logistic regression model and variance inflation factor
(VIF) was used to assess for multicollinearity [34]. The
0.05 level of significance was used throughout the statis-
tical analysis. All data analysis was conducted using Stata
version 11.1 statistical software (Stata Corp, College Sta-
tion, Tx) [35].
Before data collection, ethical approval for the study
was obtained from the Institutional Review Board of the Li
Ka-Shing Faculty of Medicine, University of Hong Kong
and from all of the participating institutions. Informed
written consent was obtained from all participants.
Results
We recruited 549 participants from the four study sites (Site
A = 159; Site B = 141; Site C = 140; Site D = 109).
Among the 549 participants, 6.2% (n = 34) reported
receiving the 2009 A/H1N1 influenza vaccine, 4.9%
(n = 27) reported receiving the seasonal influenza vaccine,
and 2.2% (n = 12) had received both vaccines. Overall,
8.9% received at least one of the vaccines and 91.1% of
participants had not received any influenza vaccine during
their pregnancy. The proportion of participants receiving
the 2009 A/H1N1 vaccine varied slightly between hospitals
(Site A: 15/144 = 9.4%; Site B: 7/141 = 5.0%; Site C:
5/135 = 3.6%; Site D: 7/102 = 6.4%).
The characteristics of the study participants according to
vaccination status are presented in Table 1. There were few
demographic differences between vaccinated and unvac-
cinated participants. In general, vaccinated mothers had a
higher education level and higher income but the differ-
ences were not statistically significant. 25.9% (n = 142) of
participants reported that they had experienced a respira-
tory infection during pregnancy, although this was also not
significantly associated with vaccination status. Vaccinated
participants were significantly more likely to have received
the seasonal influenza vaccine previously and to have a
family member who was also vaccinated against A/H1N1.
The two most common reasons for not being vaccinated
were fear of harm to the participant or the fetus (Table 2).
A total knowledge score ranging from 0 to 16 was cal-
culated based on the responses to the knowledge items. The
mean score was 6.44 (SD = 2.85), indicating overall low
knowledge levels. Mean knowledge scores were signifi-
cantly higher among the vaccinated group (10.3; SD =
3.5) when compared with the unvaccinated group (6.2;
SD = 2.6) (P \ .001). A majority of participants agreed
that 2009 A/H1N1 influenza was a serious disease that
often resulted in hospitalization (Table 3). Nevertheless,
vaccinated participants were significantly more likely to
agree that 2009 A/H1N1 influenza was more serious for
pregnant women and to believe that their fetus could
benefit from maternal 2009 A/H1N1 vaccination while in
utero and in the first 6 months of life. Less than one-third
of all participants knew that the 2009 A/H1N1 influenza
vaccine was recommended for pregnant women in Hong
Kong, with vaccinated participants significantly more
likely to know this. In addition, vaccinated participants
were significantly more likely to believe that 2009 A/H1N1
influenza vaccine was safe at all stages of pregnancy.
Overall, influenza vaccination rates were 1.8% (4/222)
among participants with low knowledge scores, 3.7% (10/
274) among participants with medium knowledge scores,
and 37.7% (20/53) among participants with high knowl-
edge scores (P \ .001).
A total attitude score ranging from 0 to 7 was calculated
based on the responses to the attitude items. The mean
attitude score for all participants was 2.3 (SD = 1.49). As
well, the mean attitude score was significantly higher
among the vaccinated group (3.9; SD = 1.5) when com-
pared with the unvaccinated group (2.2; SD = 1.4)
(P \ .001). All participants were equally concerned about
potential side effects and illness resulting from vaccination,
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though vaccinated participants were more likely to believe
the 2009 A/H1N1 influenza vaccine was effective in pre-
venting influenza (Table 4). Unvaccinated participants
were significantly more likely to agree that vaccines should
not be taken during pregnancy and that the risk of vacci-
nation was greater than the risk of 2009 A/H1N1 influenza.
Vaccination rates were 2.1% (7/327) among participants
with negative attitudes and 12.2% (27/222) among partic-
ipants with more positive attitudes (P \ .001).
Results of the logistic regression analysis identified
having a family member vaccinated with 2009 A/H1N1
influenza vaccine (OR = 7.69; 95% CI 2.92, 20.19), high
levels of knowledge (OR = 19.06; 95% CI 5.55, 65.48)
and more positive attitudes (OR = 3.52; 95% CI 1.37,
9.07) as factors independently and positively associated
with vaccination (Table 5). The Hosmer–Lemeshow
goodness-of-fit chi2 statistic for this model was 12.69
(P = 0.70), indicating a good fit for the data. VIF values
showed no evidence of multicollinearity.
Discussion
In this study we examined uptake of the 2009 A/H1N1
influenza vaccine among pregnant women in Hong Kong
during the second wave of the pandemic and identified
factors associated with vaccination. Results of this study
showed: (1) a low vaccination rate, (2) a lack of awareness
of the recommendations for vaccination among unvacci-
nated participants, (3) a high level of concern among
unvaccinated participants about the safety of the vaccine
for both the mother and the fetus, (4) better knowledge and
more positive attitudes among vaccinated participants, and
(5) greater exposure to the 2009 A/H1N1 influenza vaccine
among vaccinated participants.
2009 A/H1N1 influenza vaccination rates in this study
were similar to those reported among pregnant women in
Table 1 Characteristics of participants according to 2009 A/H1N1
influenza vaccination status
Demographic variable H1N1 influenza vaccine
uptake
P value
No Yes
N (%) N (%)
N = 515 N = 34
Age of mother
B24 years 36 (7.0) 6 (17.7) .12
25-29 years 125 (24.3) 6 (17.7)
30–34 years 236 (45.8) 13 (38.2)
C35 years 118 (22.9) 9 (26.5)
Maternal education
Compulsory secondary 264 (51.3) 15 (44.1) .14
Upper secondary 103 (20.0) 4 (11.8)
University degree or above 148 (28.7) 15 (44.1)
Family income
Less than median income 227 (44.3) 13 (38.2) .51
Median income or greater 286 (55.8) 21 (61.8)
Place of birth
Hong Kong 346 (67.2) 23 (67.7) .95
Mainland China 158 (30.7) 10 (29.4)
Other 11 (2.1) 1 (2.9)
Length of residence in Hong Kong
\10 years 72 (14.0) 4 (11.8) .85
10 to C15 years 103 (20.0) 8 (23.5)
Since birth 340 (66.0) 22 (64.7)
Breastfeeding infant
No 82 (15.9) 3 (8.8) .27
Yes 433 (84.1) 31 (91.2)
Husband smokes
No 350 (68.4) 24 (70.6) .75
Yes 162 (31.6) 10 (29.4)
Advised by HCP to receive vaccine
No 358 (69.8) 28 (82.4) .12
Yes 155 (30.2) 6 (17.7)
Received seasonal influenza vaccine before
No 392 (76.1) 20 (58.8) .02
Yes 123 (23.9) 14 (41.2)
Family member received A/H1N1 vaccine
No 478 (93.0) 19 (55.9) \.001
Yes 36 (7.0) 15 (44.1)
Family member had A/H1N1 influenza
No 505 (98.1) 32 (94.1) .13
Yes 10 (1.94) 2 (5.9)
Respiratory infection during pregnancy
No 386 (75.0) 21 (61.8) .09
Yes 129 (25.1) 13 (38.2)
Table 1 continued
Demographic variable H1N1 influenza vaccine
uptake
P value
No Yes
N (%) N (%)
N = 515 N = 34
Pre-existing chronic disease
No 490 (95.2) 33 (97.1) .61
Yes 25 (4.9) 1 (2.9)
 Median income of sample was $25,000 to $29,999 HKD per month
(1 USD = 7.78 HKD)
 Health care provider
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Australia (6.9%) [36] and Turkey (8.9%) [37] but sub-
stantially below those reported in France (22.7–37.1%) [38,
39], the US (45.7–46.6%) [40, 41], and Canada (72–76%)
[42, 43]. The 2009 A/H1N1 influenza vaccine uptake rate
among pregnant women in Hong Kong was also similar to
the uptake rate of 5% among the Hong Kong general
population [44] and the seasonal vaccine uptake rate of
3.9% among pregnant women in Hong Kong during the
2005/2006 influenza season [28]. Studies in other countries
have also shown that seasonal influenza vaccination rates
among pregnant women ranged from only 2–20% [2, 30,
45–49]. Although pregnant women were a priority group
for vaccination and the local Department of Health actively
encouraged high risk groups to receive the vaccination, the
majority of participants remained unaware that they should
be vaccinated. In addition, we collected our data during the
second wave of the A/H1N1 pandemic in the winter and
spring of 2010. At this point, the more dire predictions
about potential outcomes of a global influenza pandemic
had not been realized and overall, the pandemic was con-
sidered to be mild [9]. In Hong Kong, the A/H1N1 pan-
demic peaked in September 2009 and there were far fewer
infections in the second wave of the pandemic during the
winter of 2009–2010 [50, 51]. This may have contributed
to the low vaccination rate among pregnant women.
Influenza vaccine has been demonstrated to be safe for
pregnant women in any trimester and the risks associated
with influenza infection during pregnancy are substantial
[49, 52–54]. In addition, research has shown that influenza
vaccination during pregnancy can reduce hospitalizations
among infants \6 months of age for influenza and
influenza like illnesses by 45–63% [55–57]. Despite this
evidence, concerns about safety and side effects of influ-
enza vaccine and possible birth defects resulting from
vaccination continue to be the major reasons pregnant
women remain reluctant to receive both the seasonal and
H1N1 influenza vaccine during pregnancy [26, 30, 40,
58–62]. These findings suggest a sub-optimal response to
public health campaigns to inform pregnant women about
both the dangers of 2009 A/H1N1 influenza during preg-
nancy and the benefits and safety of the 2009 A/H1N1
influenza vaccine. Participants in this study with higher
knowledge levels, more positive attitudes and more expo-
sure to the vaccine were substantially more likely to be
vaccinated, indicating that greater education and promotion
of the vaccine may increase uptake. Accordingly, the
Centers for Disease Control and Prevention reported sub-
stantial increases in the uptake of both seasonal and 2009
A/H1N1 influenza vaccines among pregnant women in the
United States during the 2009–2010 influenza season after
focused public health education efforts [40].
In Hong Kong, it is likely that the media also played a
role in both the low uptake of vaccination and the beliefs
about potential side effects of vaccination. During the
pandemic, the local media prominently reported cases of
pregnant women who experienced miscarriages and still-
births after having received the 2009 A/H1N1 vaccine
[63–65]. There were also several cases of Guillain–Barre´
Syndrome among men after 2009 A/H1N1 vaccination that
received wide coverage in the English and Chinese press
[66]. These events often occurred weeks after vaccination
and in the case of two of the stillbirths, there were other
pregnancy complications. Despite reassurances from health
professionals that the events were unrelated to the vaccine
and that pregnant women and other groups should continue
to be vaccinated [67], the adverse events were invariably
linked to the vaccine in various media reports and vacci-
nation rates among pregnant women and other high-risk
groups fell after these incidents [44, 66].
A major source of information for pregnant women is
their health-care provider (HCP). However, fewer than
30% of participants in this study were actually advised by
their HCP to have the vaccine. Other studies done in Hong
Kong during the A/H1N1 pandemic have documented
HCPs reluctance to receive the influenza vaccine them-
selves [68, 69]. Therefore, it is not surprising that they did
not encourage pregnant women to be vaccinated. Many
HCPs are reluctant to recommend the influenza vaccine to
pregnant women because they are unaware of this recom-
mendation, they underestimate the risk of influenza during
pregnancy, they believe that the vaccine is not effective in
preventing influenza, they have concerns about the safety and
effectiveness of the vaccine during pregnancy or they do not
think it is part of their responsibility [30, 46, 59, 70, 71].
Table 2 Reasons for not receiving the 2009 A/H1N1 influenza
vaccine
N (%)
1. I was afraid that the vaccine would cause side effects
for my baby
395 (75.7)
2. I was afraid that the vaccine would cause side effects
for me
364 (69.7)
3. I was afraid that the vaccine would hurt/I am scared of
needles
103 (19.7)
4. The vaccine is unnecessary during pregnancy 75 (14.4)
5. My doctor/nurse did not recommend the vaccine 53 (10.2)
6. I was not worried about being ill with influenza during
pregnancy
58 (11.1)
7. Influenza is not a serious illness 43 (8.2)
8. My doctor/nurse did not discuss the vaccine with me 31 (5.9)
9. The vaccine is not beneficial in protecting or
preventing influenza
21 (4.0)
10. I had previous side effects from the influenza vaccine 6 (1.2)
11. Other 18 (3.5)
Note: Participants could select more than one response
Matern Child Health J
123
Although a recommendation from a HCP was not associ-
ated with vaccination status in this study, other studies
have shown that such recommendations were positively
associated with influenza vaccine uptake among pregnant
women [30, 40, 41, 61, 70]. With a novel virus, and
especially when there is misinformation and hysteria being
Table 3 Relationship between 2009 A/H1N1 influenza knowledge and vaccination status
Knowledge statement H1N1 influenza vaccine uptake P value
Not vaccinated Vaccinated
N = 515 N = 34
Agree Disagree Agree Disagree
N (%) N (%) N (%) N (%)
H1N1 influenza is highly contagious 397 (77.2) 117 (22.8) 29 (85.3) 5 (14.7) .27
H1N1 influenza can sometimes be serious enough that a person needs to be
admitted to the hospital
501 (97.9) 11 (2.2) 34 (100.0) 0 (0.0) .39
H1N1 influenza can cause a lot more illness in pregnant women than in non-
pregnant women
222 (43.1) 293 (56.9) 23 (67.7) 11 (32.4) \.01
Pregnant women are at a higher risk of developing secondary complications due to
H1N1 influenza
400 (77.7) 115 (22.3) 33 (97.1) 1 (2.9) \.01
Pregnant women are more likely to be hospitalized for H1N1 influenza than non-
pregnant women
308 (60.3) 203 (39.7) 26 (76.5) 8 (23.5) .06
My baby may benefit from maternal H1N1 influenza vaccination while in the womb 56 (10.9) 459 (89.1) 17 (51.5) 16 (48.5) \.001
H1N1 influenza vaccination during pregnancy can have a protective effect on my
baby during the first 6 months of life
75 (14.8) 433 (85.2) 14 (41.2) 20 (58.8) \.001
In Hong Kong, it is recommended that all pregnant women get the H1N1 influenza
vaccine
133 (25.8) 382 (74.2) 19 (55.9) 15 (44.1) \.001
H1N1 influenza vaccination is safe in pregnancy 46 (9.0) 467 (91.0) 18 (54.6) 15 (45.5) \.001
In pregnancy, H1N1 influenza vaccination is safe in the first trimester 51 (9.9) 464 (90.1) 10 (29.4) 24 (70.6) \.001
In pregnancy, H1N1 influenza vaccination is safe in the second trimester 65 (12.7) 448 (87.3) 20 (60.6) 13 (39.4) \.001
In pregnancy, H1N1 influenza vaccination is safe in the third trimester 62 (12.1) 452 (87.9) 15 (45.5) 18 (54.6) \.001
H1N1 influenza vaccine during pregnancy may induce spontaneous abortion 423 (82.3) 91 (17.7) 19 (57.6) 14 (42.4) \.001
H1N1 influenza vaccine during pregnancy may induce pre-term contractions 300 (58.7) 211 (41.3) 9 (27.3) 24 (72.7) \.001
H1N1 influenza vaccine during pregnancy can cause birth defects 257 (50.4) 253 (49.6) 7 (20.6) 27 (79.4) .001
My baby might get the flu in the womb if I get the H1N1 influenza vaccine during
pregnancy
197 (38.6) 314 (61.5) 7 (20.6) 27 (79.4) \.05
Table 4 Relationship between 2009 A/H1N1 influenza attitudes and vaccination status
Attitude statement H1N1 influenza Vaccine P value
Not vaccinated Vaccinated
N = 515 N = 34
Agree Disagree Agree Disagree
N (%) N (%) N (%) N (%)
H1N1 influenza vaccines are effective in protecting people and preventing illness 254 (50.0) 254 (50.0) 31 (91.2) 3 (8.8) \.001
I am concerned about side effects from the H1N1 influenza vaccine 493 (95.9) 21 (4.1) 32 (94.1) 2 (5.9) .61
H1N1 influenza vaccine can cause severe illness 376 (73.6) 135 (26.4) 23 (67.7) 11 (32.4) .45
H1N1 influenza vaccine can cause a person to be sick with the flu 165 (32.4) 345 (67.7) 10 (30.3) 23 (69.7) .81
For healthy people, H1N1 influenza vaccine should be avoided 382 (74.5) 131 (25.5) 18 (52.9) 16 (47.1) \.01
I think health care workers should be vaccinated against H1N1 influenza 335 (65.3) 178 (34.7) 30 (88.2) 4 (11.8) \.01
For pregnant women, the risk of the H1N1 influenza vaccination is greater than the
risk of getting influenza
372 (72.4) 142 (27.6) 9 (26.5) 25 (73.5) \.001
All vaccines should be avoided during pregnancy 406 (78.8) 109 (21.2) 10 (29.4) 24 (70.6) \.001
Matern Child Health J
123
generated by the media, the role of the HCP in providing
factual information and reassurance to pregnant women is
more important because of uncertainty about the vaccine
and the potential consequences [40]. In addition, publicly-
funded antenatal clinics in Hong Kong do not provide on-
site vaccination, a situation that is similar to other countries
[30]. Therefore, even if pregnant women are advised to get
the vaccine, they have to go elsewhere to be vaccinated and
thus may be less likely to seek out the vaccine. Offering
and providing the influenza vaccine in the antenatal clinic
setting has been shown to substantially increase vaccina-
tion uptake rates [72].
Participants in this study with a family member who had
received the 2009 A/H1N1 influenza vaccine were substan-
tially more likely to be vaccinated. Exposure to vaccinated
persons may help to decrease the perception of risk from
vaccination. In addition, if one family member requires
vaccination, especially if it is medically indicated, HCPs
may be more likely to recommend vaccination to all family
members. Similar to findings from other studies [39, 73],
participants who had pre-existing co-morbid conditions were
no more likely to receive the vaccine than those without pre-
existing conditions. Again, this may be due to lack of
awareness of the recommendation for vaccination and/or the
failure of health professionals to advise pregnant women
with underlying chronic diseases to receive the vaccine.
Strengths and Limitations
This study is one of a number of studies to report on the
actual uptake of 2009 A/H1N1 influenza vaccine among
pregnant women during the 2009–2010 A/H1N1 pandemic
[36, 37, 39, 40, 42, 43], but to our knowledge the first in
Asia. We recruited our sample from four geographically
and socio-economically disparate hospitals across Hong
Kong. As such, it provides a baseline for further research
and can help to inform public health education and pro-
motion programmes concerning influenza vaccine for
pregnant women. Since we recruited new mothers in the
immediate post-partum period, we measured actual uptake
of vaccination during pregnancy and not just simply the
intention to be vaccinated [74], which has been demon-
strated to be an unreliable indicator of actual vaccination
[44, 75]. This study however, has several limitations. First,
although we recruited participants from four hospitals, the
sample was not population based and no data were collected
from participants who refused to participate. Also, we do
not know what proportion of eligible mothers chose not to
participate. Second, our sample participated voluntarily and
therefore, we cannot rule out the possibility that participants
who had been vaccinated and had higher knowledge of 2009
A/H1N1 influenza were more likely to participate. Hence, if
anything, the study results likely overestimate the uptake of
2009 A/H1N1 influenza vaccine among pregnant women in
Hong Kong. Third, the low number of respondents who
were actually vaccinated limited the statistical power of the
study and thus our ability to identify factors significantly
associated with vaccination uptake. In addition, researchers
have pointed out that the use of logistic regression with
samples that have highly skewed outcomes, such as what
was found in this study, may result in overestimation of the
odds ratios [76]. Thus, further research with a larger pop-
ulation-based sample is necessary to corroborate the study
findings and to provide further insight into factors affecting
influenza vaccine uptake.
Conclusions
Poor uptake of 2009 A/H1N1 influenza vaccination among
pregnant women in Hong Kong was related to low
knowledge levels, poor attitudes, and fear of vaccine side
effects for the mother and baby. Increasing knowledge and
awareness about the benefits of influenza vaccination for
both the mother and the baby may increase uptake rates of
both pandemic and seasonal influenza vaccine. Improving
education for obstetric health-care providers, encouraging
them to recommend vaccination for pregnant women and
on-site provision of influenza vaccine in antenatal clinics
could also improve vaccination rates. Finally, it is also
important to further explore the influence of both HCPs and
the media in pregnant women’s decision making regarding
influenza vaccine.
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Table 5 Logistic regression analysis of the predictors of 2009
A/H1N1 influenza vaccination
Adjusted OR (95% CI) P value
Received seasonal influenza vaccine before
No 1
Yes 1.30 (0.52, 3.21) 0.56
Family member received A/H1N1 influenza vaccine
No 1
Yes 7.69 (2.92, 20.19) \0.001
Knowledge scores
Low 1
Medium 1.40 (0.41, 4.77) 0.59
High 19.06 (5.55, 65.48) \0.001
Attitude scores
Low 1
High 3.52 (1.37, 9.07) \0.01
Matern Child Health J
123
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Cox, S., Posner, S. F., McPheeters, M., Jamieson, D. J., Kourtis,
A. P., & Meikle, S. (2006). Influenza and pregnant women:
Hospitalization burden, United States, 1998–2002. Journal of
Women’s Health, 15(8), 891–893.
2. Dodds, L., McNeil, S. A., Fell, D. B., Allen, V. M., Coombs, A.,
Scott, J., et al. (2007). Impact of influenza exposure on rates of
hospital admissions and physician visits because of respiratory
illness among pregnant women. CMAJ, 176(4), 463–468.
3. Cox, S., Posner, S. F., McPheeters, M., Jamieson, D. J., Kourtis,
A. P., & Meikle, S. (2006). Hospitalizations with respiratory
illness among pregnant women during influenza season. Obstet-
rics and Gynecology, 107(6), 1315–1322.
4. Irving, W. L., James, D. K., Stephenson, T., Laing, P., Jameson,
C., Oxford, J. S., et al. (2000). Influenza virus infection in the
second and third trimesters of pregnancy: A clinical and se-
roepidemiological study. BJOG, 107(10), 1282–1289.
5. Neuzil, K. M., Reed, G. W., Mitchel, E. F., Simonsen, L., &
Griffin, M. R. (1998). Impact of influenza on acute cardiopul-
monary hospitalizations in pregnant women. American Journal of
Epidemiology, 148(11), 1094–1102.
6. Schanzer, D. L., Langley, J. M., & Tam, T. W. S. (2007).
Influenza-attributed hospitalization rates among pregnant women
in Canada 1994–2000. Journal of Obstetrics and Gynaecology
Canada, 29(8), 622–629.
7. Zarocostas, J. (2009). World Health Organization declares A
(H1N1) influenza pandemic. BMJ, 338, b2425.
8. Centre for health protection. (2009). SFH on human swine flu.
Hong Kong: Author. Accessed 2011 October 12. Available from:
http://www.chp.gov.hk/en/content/116/16787.html.
9. Leung, G. M., & Nicoll, A. (2010). Reflections on pandemic
(H1N1) 2009 and the international response. PLoS Medicine, 7(10).
10. Jamieson, D. J., Honein, M. A., Rasmussen, S. A., Williams, J.
L., Swerdlow, D. L., Biggerstaff, M. S., et al. (2009). H1N1 2009
influenza virus infection during pregnancy in the USA. Lancet,
374(9688), 451–458.
11. Centers for disease control and prevention. (2009). Pregnant
women and novel influenza A (H1N1) virus: Considerations for
clinicians. Atlanta, GA: Author. [updated July 27, 2009; Acces-
sed 2011 May 24]; Available from: http://www.cdc.gov/h1n1flu/
clinician_pregnant.html.
12. Siston, A. M., Rasmussen, S. A., Honein, M. A., Fry, A. M., Seib,
K., Callaghan, W. M., et al. (2010). Pandemic 2009 influenza
A(H1N1) virus illness among pregnant women in the United
States. JAMA, 303(15), 1517–1525.
13. Dubar, G., Azria, E., Tesnie`re, A., Dupont, H., Le Ray, C., Bau-
gnon, T., et al. (2010). For the French Registry on 2009 A/H1N1v
during pregnancy. French experience of 2009 A/H1N1v influenza
in pregnant women. PLoS One, 5(10), e13112.
14. Hanslik, T., Boelle, P.-Y., & Flahault, A. (2010). Preliminary
estimation of risk factors for admission to intensive care units and
for death in patients infected with A(H1N1)2009 influenza virus,
France, 2009–2010. PLoS Current, 2, RRN1150.
15. Knight, M., Pierce, M., Seppelt, I., Kurinczuk, J. J., Spark, P.,
Brocklehurst, P., et al. (2011). Critical illness with AH1N1v
influenza in pregnancy: A comparison of two population-based
cohorts. BJOG, 118(2), 232–239.
16. Anzic Influenza Investigators and Australasian Maternity Out-
comes Surveillance System. (2009). A/H1N1 influenza in preg-
nant and postpartum women: Population based cohort study.
BMJ, 2010(340), c1279.
17. Lim, M. L., Chong, C. Y., Tee, W. S. N., Lim, W. Y., & Chee, J.
J. (2010). Influenza A/H1N1 (2009) infection in pregnancy—an
Asian perspective. BJOG, 117(5), 551–556.
18. Lim, M. L., Lim, W. Y., Tee, N. W. S., Lim, S. H., & Chee, J. J.
(2010). Obstetric outcomes of influenza A H1N1 (2009) infection
in pregnancy—experience of a Singapore tertiary hospital.
Annals of the Academy of Medicine, Singapore, 39(4), 295–298.
19. Hospital Authority. (2010). Pandemic H1N1 influenza admissions
to public hospitals in Hong Kong (unpublished data). Hong
Kong.
20. Ayoub, D. M., & Yazbak, F. E. (2008). A closer look at influenza
vaccination during pregnancy. Lancet Infectious Diseases, 8(11),
660–661.
21. Skowronski, D. M., & De Serres, G. (2009). Is routine influenza
immunization warranted in early pregnancy? Vaccine, 27(35),
4754–4770.
22. Scientific Committee on Vaccine Preventable Diseases. (2010).
Recommendations on influenza vaccination for the 2010/11 sea-
son. Hong Kong: Centre for Health Protection.
23. National Advisory Committee on Immunization (NACI). (2011).
Statement on seasonal influenza vaccine for 2011–2012. Canada
Communicable Disease Report, 37(ACS-5), 1–55.
24. National Health and Medical Research Council. (2008). The
Australian immunisation handbook (9th ed., pp. 1–413). Austra-
lian Government Department of Health and Ageing.
25. Centers for Disease Control and Prevention. (2011). Prevention
and control of influenza with vaccines: Recommendations of the
Advisory Committee on Immunization Practices (ACIP), 2011.
MMWR Morbidity and Mortality Weekly Report, 60(33),
1128–1132.
26. Naleway, A. L., Smith, W. J., & Mullooly, J. P. (2006). Deliv-
ering influenza vaccine to pregnant women. Epidemiologic
Reviews, 28(1), 47–53.
27. Fielding, R. (2010). Pandemic influenza A/H1N1 (pH1N1) in
Hong Kong: Anatomy of a response. NTS Working Paper Series
No. 3. Singapore: RSIS Centre for Non-Traditional Security
(NTS) Studies.
28. Lau, J. T., Cai, Y., Tsui, H. Y., & Choi, K. C. (2010). Prevalence
of influenza vaccination and associated factors among pregnant
women in Hong Kong. Vaccine, 28(33), 5389–5397.
29. Lee, J. W., Jones, P. S., Mineyama, Y., & Zhang, X. E. (2002).
Cultural differences in responses to a Likert scale. Research in
Nursing and Health, 25(4), 295–306.
30. Tong, A., Biringer, A., Ofner-Agostini, M., Upshur, R., &
McGeer, A. (2008). A cross-sectional study of maternity care
providers’ and women’s knowledge, attitudes, and behaviours
towards influenza vaccination during pregnancy. Journal of
Obstetrics and Gynaecology Canada, 30(5), 404–410.
31. Brislin, R. W. (1986). The wording and translation of research
instruments. In W. J. Loner & J. W. Berry (Eds.), Field methods
in cross-cultural research (pp. 137–164). Beverly Hills, CA:
Sage.
32. Chapman, D. W., & Carter, J. F. (1979). Translation procedures
for the cross-cultural use of measurement. Educational Evalua-
tion and Policy Analysis, 1(3), 71–76.
33. Hosmer, D. W., Hosmer, T., Le Cessie, S., & Lemeshow, S.
(1997). A comparison of goodness-of-fit tests for the logistic
regression model. Statistics in Medicine, 16(9), 965–980.
34. Hair, J. F. (2010). Multivariate data analysis (7th ed.). Upper
Saddle River, NJ: Prentice Hall.
35. StataCorp. (2010). Stata statistical software: Release 11.1. Col-
lege Station, TX: StataCorp LP.
Matern Child Health J
123
36. White, S. W., Petersen, R. W., & Quinlivan, J. A. (2010). Pan-
demic (H1N1) 2009 influenza vaccine uptake in pregnant women
entering the 2010 influenza season in Western Australia. Medical
Journal of Australia, 193(7), 405–407.
37. Ozer, A., Arikan, D. C., Kirecci, E., & Ekerbicer, H. C. (2010).
Status of pandemic influenza vaccination and factors affecting it
in pregnant women in Kahramanmaras, an eastern Mediterranean
city of Turkey. PLoS One, 5(12), e14177.
38. Bone, A., Guthmann, J.-P., Nicolau, J., & Levy-Bruhl, D. (2010).
Population and risk group uptake of H1N1 influenza vaccine in
mainland France 2009–2010: Results of a national vaccination
campaign. Vaccine, 28(51), 8157–8161.
39. Freund, R., Le Ray, C., Charlier, C., Avenell, C., Truster, V.,
Treluyer, J. M., et al. (2011). Determinants of non-vaccination
against pandemic 2009 H1N1 influenza in pregnant women: A
prospective cohort study. PLoS ONE, 6(6), e20900.
40. Centers for Disease Control and Prevention. (2010). Seasonal
influenza and 2009 H1N1 influenza vaccination coverage among
pregnant women—10 states, 2009–10 influenza season. MMWR
Morbidity and Mortality Weekly Report, 59(47), 1541–1545.
41. Ding, H., Santibanez, T. A., Jamieson, D. J., Weinbaum, C. M.,
Euler, G. L., Grohskopf, L. A., et al. (2011). Influenza vaccina-
tion coverage among pregnant women—National 2009 H1N1 Flu
Survey (NHFS). American Journal of Obstetrics and Gynecology,
204(6 Suppl 1), S96–S106.
42. Fabry, P., Gagneur, A., & Pasquier, J. C. (2011). Determinants of
A (H1N1) vaccination: Cross-sectional study in a population of
pregnant women in Quebec. Vaccine, 29(9), 1824–1829.
43. Gracie, S., Metcalfe, A., Dolan, S. M., Kehler, H., Siever, J., &
Tough, S. (2011). Utilization of the 2009 H1N1 vaccine by
pregnant women in a pandemic year. Journal of Obstetrics and
Gynaecology Canada, 33(2), 127–133.
44. Liao, Q., Cowling, B. J., Lam, W. W., & Fielding, R. (2011).
Factors affecting intention to receive and self-reported receipt of
2009 pandemic (H1N1) vaccine in Hong Kong: A longitudinal
study. PLoS One, 6(3), e17713.
45. Black, S. B., Shinefield, H. R., France, E. K., Fireman, B. H.,
Platt, S. T., & Shay, D. (2004). Effectiveness of influenza vaccine
during pregnancy in preventing hospitalizations and outpatient
visits for respiratory illness in pregnant women and their infants.
American Journal of Perinatology, 21(6), 333–339.
46. Silverman, N. S., & Greif, A. (2001). Influenza vaccination
during pregnancy. Patients’ and physicians’ attitudes. Journal of
Reproductive Medicine, 46(11), 989–994.
47. Tuyishime, J. D., De Wals, P., Moutquin, J. M., & Frost, E.
(2003). Influenza-like illness during pregnancy: Results from a
study in the eastern townships, Province of Quebec. Journal of
Obstetrics and Gynaecology Canada, 25(12), 1020–1025.
48. France, E. K., Smith-Ray, R., McClure, D., Hambidge, S., Xu, S.,
Yamasaki, K., et al. (2006). Impact of maternal influenza vacci-
nation during pregnancy on the incidence of acute respiratory
illness visits among infants. Archives of Pediatrics and Adoles-
cent Medicine, 160(12), 1277–1283.
49. Munoz, F. M., Greisinger, A. J., Wehmanen, O. A., Mouzoon, M.
E., Hoyle, J. C., Smith, F. A., et al. (2005). Safety of influenza
vaccination during pregnancy. American Journal of Obstetrics
and Gynecology, 192(4), 1098–1106.
50. Centre for Health Protection. (2010). Consultation rate of influ-
enza-like illness and number of influenza isolates, 2009. Hong
Kong: Author. Accessed 2011 October 12; Available from:
http://www.chp.gov.hk/en/data/1/26/44/292/378.html.
51. Centre for Health Protection. (2011). Consultation rate of influ-
enza-like illness and number of influenza isolates, 2010. Hong
Kong: Author. Accessed 2011 October 12; Available from:
http://www.chp.gov.hk/en/data/1/26/44/292/420.html.
52. Yeager, D. P., Toy, E. C., & Baker, B., 3rd. (1999). Influenza
vaccination in pregnancy. American Journal of Perinatology,
16(6), 283–286.
53. Pool, V., & Iskander, J. (2006). Safety of influenza vaccination
during pregnancy. American Journal of Obstetrics and Gyne-
cology, 194(4), 1200.
54. Omon, E., Damase-Michel, C., Hurault-Delarue, C., Lacroix, I.,
Montastruc, J. L., Oustric, S., et al. (2011). Non-adjuvant 2009
influenza A (H1N1)v vaccine in pregnant women: The results of a
French prospective descriptive study. Vaccine, 29(52), 9649–9654.
55. Poehling, K. A., Szilagyi, P. G., Staat, M. A., Snively, B. M.,
Payne, D. C., Bridges, C. B., et al. (2011). Impact of maternal
immunization on influenza hospitalizations in infants. American
Journal of Obstetrics and Gynecology, 204(6, Supplement),
S141–S148.
56. Zaman, K., Roy, E., Arifeen, S. E., Rahman, M., Raqib, R.,
Wilson, E., et al. (2008). Effectiveness of maternal influenza
immunization in mothers and infants. New England Journal of
Medicine, 359(15), 1555–1564.
57. Blanchard-Rohner, G., & Siegrist, C.-A. (2011). Vaccination
during pregnancy to protect infants against influenza: Why and
why not? Vaccine, 29(43), 7542–7550.
58. Ahluwalia, I. B., Jamieson, D. J., Rasmussen, S. A., D’Angelo,
D., Goodman, D., & Kim, H. (2010). Correlates of seasonal
influenza vaccine coverage among pregnant women in Georgia
and Rhode Island. Obstetrics and Gynecology, 116(4), 949–955.
59. Broughton, D. E., Beigi, R. H., Switzer, G. E., Raker, C. A., &
Anderson, B. L. (2009). Obstetric health care workers’ attitudes
and beliefs regarding influenza vaccination in pregnancy.
Obstetrics and Gynecology, 114(5), 981–987.
60. Yudin, M. H., Salaripour, M., & Sgro, M. D. (2009). Pregnant
women’s knowledge of influenza and the use and safety of the
influenza vaccine during pregnancy. Journal of Obstetrics and
Gynaecology Canada, 31(2), 120–125.
61. Lynch, M. M., Mitchell, E. W., Williams, J. L., Brumbaugh, K.,
Jones-Bell, M., Pinkney, D. E., et al. (in press). Pregnant and
recently pregnant women’s perceptions about influenza A pan-
demic (H1N1) 2009: Implications for public health and provider
communication. Maternal and Child Health Journal. doi:
10.1007/s10995-011-0865-y.
62. SteelFisher, G. K., Blendon, R. J., Bekheit, M. M., Mitchell, E.
W., Williams, J., et al. (2011). Novel pandemic A (H1N1)
influenza vaccination among pregnant women: Motivators and
barriers. American Journal of Obstetrics and Gynecology, 204(6,
Supplement), S116–S123.
63. Chi-fai, C. (2010). Third woman suffers stillbirth after having
swine flu vaccination. South China Morning Post.
64. Ng, Y.-h. (2010). Woman loses baby; flu jab not to blame, doc-
tors say. South China Morning Post.
65. Ng, Y.-h. (2010). 4 women lost babies after shots, but vaccine not
cause, says official. South China Morning Post.
66. Benitez, M. A. (2010). Swine flu jab takes hit as man, 91, falls ill.
The Standard.
67. Ng, Y.-h. (2010). Pregnant women told to continue flu shots.
South China Morning Post.
68. Chor, J. S., Ngai, K. L., Goggins, W. B., Wong, M. C., Wong, S.
Y., Lee, N., et al. (2009). Willingness of Hong Kong healthcare
workers to accept pre-pandemic influenza vaccination at different
WHO alert levels: Two questionnaire surveys. BMJ, 339, b3391.
69. Wong, S. Y., Wong, E. L., Chor, J., Kung, K., Chan, P. K., Wong,
C., et al. (2010). Willingness to accept H1N1 pandemic influenza
vaccine: a cross-sectional study of Hong Kong community nur-
ses. BMC Infectious Diseases, 10, 316.
70. Esposito, S., Tremolati, E., Bellasio, M., Chiarelli, G., Marchisio,
P., Tiso, B., et al. (2007). Attitudes and knowledge regarding
Matern Child Health J
123
influenza vaccination among hospital health workers caring for
women and children. Vaccine, 25(29), 5283–5289.
71. Mersereau, P. W., Layton, C. M., Smith, L. R., Kendrick, J. S.,
Mitchell, E. W., Amoozegar, J. B., et al. (in press). Prenatal care
providers and influenza prevention and treatment: Lessons from the
field. Maternal and Child Health Journal. doi:10.1007/s10995-
011-0753-5.
72. Yudin, M. H., Salaripour, M., & Sgro, M. D. (2010). Accept-
ability and feasibility of seasonal influenza vaccine administra-
tion in an antenatal clinic setting. Journal of Obstetrics and
Gynaecology Canada, 32(8), 745–748.
73. Rehmet, S., Ammon, A., Pfaff, G., Bocter, N., & Petersen, L. R.
(2002). Cross-sectional study on influenza vaccination, Germany,
1999–2000. Emerging Infectious Diseases, 8(12), 1442–1447.
74. Tucker Edmonds, B., Coleman, J., Armstrong, K., & Shea, J.
(2011). Risk perceptions, worry, or distrust: What drives pregnant
women’s decisions to accept the H1N1 vaccine? Maternal Child
Health Journal, 15, 1203–1209.
75. Kwon, Y., Cho, H.-Y., Lee, Y.-K., Bae, G.-R., & Lee, S.-G.
(2010). Relationship between intention of novel influenza A
(H1N1) vaccination and vaccination coverage rate. Vaccine,
29(2), 161–165.
76. Nemes, S., Jonasson, J. M., Genell, A., & Steineck, G. (2009).
Bias in odds ratios by logistic regression modelling and sample
size. BMC Medical Research Methodology, 9(56).
Matern Child Health J
123
